BTF3 divergent transcript (BTF3-DT)

BTF3 divergent transcript (BTF3-DT) is a noncoding RNA identified by its transcriptional activity in a divergent orientation relative to the BTF3 gene locus. Divergent transcription is a common genomic phenomenon, especially at promoters and enhancers, leading to simultaneous transcription in both directions and often yielding noncoding RNAs. These transcripts may play regulatory roles or represent transcriptional noise, with most being short, unstable, and functionally uncharacterized. BTF3-DT does not correspond to a mapped protein, receptor, enzyme, or drug target, and its biological or pathological functions—if any—are not established. The naming convention reflects its genomic association rather than a curated therapeutic function. The BTF3 gene encodes basic transcription factor 3, involved in transcriptional regulation and widely studied in cancer biology. The divergent transcript is distinct from the protein-coding BTF3 and lacks established function as a molecular target. In genomic research, “divergent transcript” denotes an RNA transcribed in the direction opposite to a protein-coding gene, resulting from the architecture of bidirectional promoters. BTF3 divergent transcript is an uncharacterized noncoding RNA associated with the BTF3 locus and does not represent a canonical molecular target for therapeutics, biomarker development, or drug interaction. The entry is best classified as incorrect for the purposes of molecular target databases.

Other names

BTF3-DTBTF3 divergent transcript

None described. Mechanism of action applies to protein targets or druggable molecules, not noncoding transcripts like BTF3-DT